Regeneron Pharmaceuticals
An Associate Director in Clinical Imaging leads the development and implementation of imaging biomarker strategies for cardiovascular and metabolic indications in clinical trials. The role involves collaboration across teams to design and validate novel imaging-based biomarkers and ensure high-quality imaging data delivery.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Clinical Imaging Director
Amgen
Director / Senior Director Clinical Imaging Research Scientist
Eli Lilly and Company
Director, Imaging Biomarkers
Dyne Therapeutics
Director, Oncology Imaging - (Remote)
Eisai
Clinical Imaging Scientist Translational Radiology Waltham Massachusetts United States Of America
AstraZeneca
Cardiovascular Imaging Radiologist
University of Wisconsin–Madison